PrEp, the once-daily medication has been proven to reduce the risk of HIV infection, particularly among members of the gay community, by up to 90 per cent.

Health authorities have begun a formal process to evaluate the possibility of introducing a State-funded HIV prevention drug. The anti-HIV Pre-Exposu(...)

Declan Black, managing partner of Mason Hayes & Curran. “I do expect to return to growth this year...solid single-digit percentage growth.” Photograph: Eric Luke

Irish law firm Mason Hayes & Curran recorded a 1.2 per cent drop in its turnover last year, largely due to Brexit-related nervousness among client(...)

Teva has been struggling of late, as pressure from both rivals and customers has grown. Photograph: Bloomberg

Teva Pharmaceutical’s US-listed shares received a shot in the arm on Friday following a report that the struggling Israeli drugmaker could be looking (...)

Anti-HIV drug Pre-Exposure Prophylaxis (PrEP) will be available for purchase in Ireland from next Monday, Taoiseach Leo Varadkar confirmed on Friday. (...)

None of the grounds put forward by Teva was accepted by the High Court and the judge therefore declined to grant the order sought. Photograph: iStock

An Irish pharmaceutical company has failed to get a High Court order revoking a patent for an invention related to an inhalation capsule used in the t(...)

Medicines for Ireland is an amalgamation of the Healthcare Enterprise Alliance and the Irish Generic Manufacturers’ Association. Photograph: Getty Images

A new alliance of generic drug manufacturers has warned that Irish patients will face increasing difficulty accessing lifesaving medicines without ref(...)

Norton (Waterford) Ltd, trading as Teva Pharmaceuticals Ireland, wants the court to order revocation of a patent issued to Boehringer Ingelheim International GMBH for its Spiriva Handihaler device.

Two drug companies are in dispute over the patent for an alleged invention related to an inhalation capsule used in the treatment of chronic obstructi(...)

Israeli drugmaker Teva Pharmaceuticals has agreed to buy Allergan’s generic- drug business for about $40.5 billion.

Israeli drugmaker Teva Pharmaceuticals raised its full-year earnings forecast as it announced it agreed to buy Allergan’s generic-drug business. Teva(...)

EirGen employs 100 and manufactures high potency drugs for cancer chemotherapy

Waterford-based pharmaceutical company EirGen has been acquired by US drugs company Opko for $135 million. Founded by Tom Brennan and Patsy Carney (...)

A generic form of the drug Plavix sits on crates at a Mylan Pharmaceuticals distribution centre. The drug maker Mylan has offered to acquire Perrigo for about $29 billion in what would be the latest mega-merger among drug makers if it is completed. Photograph: Travis Dove/The New York Times

It’s been a busy few weeks for US pharma giant Mylan, which reports quarterly earnings today. Firstly, it made a proposal to buy Dublin-based Perrigo,(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • Next
  • Last »